Loading company…
Ra Pharmaceuticals develops treatments for rare diseases using proprietary technologies.
Ra Pharmaceuticals develops biopharmaceutical treatments for people with rare diseases, using proprietary technologies. The company was founded in 2008 and is based in Cambridge, US. It raised USD 92 mn in an IPO on October 25, 2016, and is at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in